Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwamoto, F. M.
Right arrow Articles by Abrey, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwamoto, F. M.
Right arrow Articles by Abrey, L. E.
Related Collections
Right arrow All Clinical trials
Right arrow All Oncology
Right arrow Primary brain tumor
Right arrow Clinical trials Observational study (Cohort, Case control)
NEUROLOGY 2006;66:1763-1765
© 2006 American Academy of Neurology
Brief Communications

Primary dural lymphomas: A clinicopathologic study of treatment and outcome in eight patients

Fabio M. Iwamoto, MD, Lisa M. DeAngelis, MD and Lauren E. Abrey, MD

From the Department of Neurology and Neuroscience (F.M.I.), Weill Medical College of Cornell University, New York, NY; and Department of Neurology (L.M.D., L.E.A.), Memorial Sloan-Kettering Cancer Center, New York, NY.

Address correspondence and reprint requests to Dr. Lauren E. Abrey, Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021; e-mail: abreyl{at}mskcc.org

The authors report eight patients with primary dural lymphoma (PDL). All patients had extra-axial masses on MRI that diffusely enhanced after gadolinium. Pathology revealed low-grade non-Hodgkin lymphoma (marginal zone lymphoma of MALT [mucosa-associated lymphoid tissue] type) in all patients. All patients underwent radiation therapy, and three received chemotherapy. Complete response was achieved in 100% of patients, but three developed systemic relapse.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the June 13 issue to find the title link for this article.

Disclosure: The authors report no conflicts of interest.

Received September 7, 2005. Accepted in final form February 22, 2006.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.